3.17
price down icon0.31%   -0.01
after-market 시간 외 거래: 3.17
loading
전일 마감가:
$3.18
열려 있는:
$3.29
하루 거래량:
3.02M
Relative Volume:
1.60
시가총액:
$514.92M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
79.25
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
-5.93%
1개월 성능:
+105.84%
6개월 성능:
+385.90%
1년 성능:
-9.94%
1일 변동 폭
Value
$3.05
$3.44
1주일 범위
Value
$2.96
$3.47
52주 변동 폭
Value
$0.5271
$5.1288

아이언우드 제약 Stock (IRWD) Company Profile

Name
명칭
Ironwood Pharmaceuticals Inc
Name
전화
617-621-7722
Name
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
직원
253
Name
트위터
@ironwoodpharma
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
IRWD's Discussions on Twitter

IRWD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
3.17 517.32M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
115.89 51.60B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.06 44.51B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.60 42.35B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
24.28 28.04B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
474.72 20.52B 3.08B 1.24B 1.07B 25.61

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-15 다운그레이드 Jefferies Buy → Hold
2025-04-15 다운그레이드 Wells Fargo Overweight → Equal Weight
2025-04-14 다운그레이드 Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 개시 Leerink Partners Market Perform
2024-08-08 다운그레이드 CapitalOne Overweight → Equal Weight
2024-01-17 개시 Craig Hallum Buy
2023-12-14 개시 Wells Fargo Overweight
2023-11-09 개시 Jefferies Buy
2023-09-28 개시 JMP Securities Mkt Outperform
2022-09-02 개시 CapitalOne Overweight
2022-04-22 개시 Piper Sandler Overweight
2020-09-30 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-06-17 개시 Northland Capital Outperform
2019-07-10 재개 Credit Suisse Neutral
2019-03-27 업그레이드 Morgan Stanley Underweight → Equal-Weight
2019-02-25 업그레이드 H.C. Wainwright Sell → Neutral
2019-01-24 업그레이드 JP Morgan Underweight → Neutral
2018-11-07 다운그레이드 Credit Suisse Outperform → Neutral
2018-11-07 다운그레이드 JP Morgan Neutral → Underweight
2018-07-23 개시 H.C. Wainwright Sell
2018-05-09 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2018-01-05 다운그레이드 BofA/Merrill Buy → Underperform
2017-12-06 다운그레이드 Mizuho Buy → Neutral
2017-07-21 다운그레이드 JP Morgan Overweight → Neutral
2017-05-03 개시 Wells Fargo Outperform
2017-04-07 재확인 Mizuho Buy
2017-02-22 재확인 Barclays Equal Weight
2016-11-04 재확인 Mizuho Buy
2016-10-24 재확인 Wedbush Neutral
2016-10-10 재확인 Mizuho Buy
2016-09-27 재확인 WallachBeth Hold
모두보기

아이언우드 제약 주식(IRWD)의 최신 뉴스

pulisher
02:25 AM

How Ironwood Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

02:25 AM
pulisher
01:22 AM

How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflationInsider Buying & Technical Entry and Exit Tips - newser.com

01:22 AM
pulisher
Nov 19, 2025

Is Ironwood Pharmaceuticals Inc. (I76) stock attractive for dividend growthJuly 2025 Review & Capital Protection Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunityMarket Growth Report & Smart Allocation Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Ironwood Pharmaceuticals Inc. (I76) stock moves on employment dataPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Ironwood Pharmaceuticals Inc. (I76) stock deliver strong annual returnsWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Price Momentum & AI Enhanced Trading Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ironwood Pharmaceuticals Inc. stock outperform Dow Jones indexJuly 2025 Earnings & Safe Swing Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryMarket Activity Report & Real-Time Market Trend Scan - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Ironwood Pharmaceuticals Inc. stock continue upward trendDip Buying & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Ironwood Pharmaceuticals Inc. outperform the marketWeekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value of Ironwood Pharmaceuticals Inc. stock nowWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Published on: 2025-11-18 19:33:35 - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

What’s next for Ironwood Pharmaceuticals Inc. stock priceTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Will Ironwood Pharmaceuticals Inc. stock maintain dividend yieldPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Live market analysis of Ironwood Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderDollar Strength & Weekly Setup with ROI Potential - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Ironwood Pharmaceuticals (IRWD) Price Target Increased by 89.47% to 1.84 - Nasdaq

Nov 17, 2025

아이언우드 제약 (IRWD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$33.62
price down icon 6.17%
$21.24
price down icon 1.03%
drug_manufacturers_specialty_generic RDY
$13.90
price down icon 1.07%
$10.19
price down icon 2.58%
$138.98
price up icon 0.67%
$474.72
price down icon 0.38%
자본화:     |  볼륨(24시간):